| Literature DB >> 23755744 |
R Mazzucchelli1, M Scarpelli, A Lopez-Beltran, L Cheng, R Di Primio, R Montironi.
Abstract
Treatment options for prostate cancer consist of radical prostatectomy, hormonal therapy and radiation therapy. Hormonal and radiation therapy have well-known, often profound, effects on the histological appearance of benign and malignant prostate tissue. Novel therapies including focal ablative treatments, chemotherapies and targeted molecular therapies are beginning to emerge and pathologists will play a central role in documenting the effects of these treatments at the tissue level. As such, knowledge of treatment-related changes and access to clinical information are essential to ensure accurate interpretation and reporting of post-treatment prostate specimens by pathologists.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23755744 DOI: 10.1177/039463201302600202
Source DB: PubMed Journal: Int J Immunopathol Pharmacol ISSN: 0394-6320 Impact factor: 3.219